Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | WEE1 | P30291 | 1/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | TERT | O14746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20224478 | 0.99 | WEE1 (0.33) | PDK2WEE1PLA2G2APLA2G4AKMT2A | |
| SCHEMBL18156761 | 0.98 | WEE1 (0.33) | PDK2WEE1PLA2G2APLA2G4AKMT2A | |
| SCHEMBL20224484 | 0.97 | PLA2G2A (0.33) | PDK2WEE1PLA2G2APLA2G4AKMT2A | |
| SCHEMBL18732064 | 0.97 | PDK2 (0.34) | PDK2WEE1PLA2G2APLA2G4AKMT2A | |
| SCHEMBL24039488 | 0.96 | KMT2A (0.32) | WEE1PLA2G2APLA2G4AKMT2AALDH1A1 | |
| SCHEMBL19131547 | 0.95 | PLA2G2A (0.34) | PDK2WEE1PLA2G2APLA2G4AKMT2A | |
| SCHEMBL20224485 | 0.94 | KMT2A (0.35) | WEE1KMT2AALDH1A1HPGDMAPT | |
| SCHEMBL20224499 | 0.94 | KMT2A (0.34) | PDK2WEE1KMT2AALDH1A1HPGD | |
| SCHEMBL18732056 | 0.93 | KMT2A (0.34) | PDK2WEE1PLA2G2APLA2G4AKMT2A | |
| SCHEMBL20224480 | 0.92 | PDK2 (0.39) | PDK2KMT2AALDH1A1HPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11183641-B2 | Composition for an organic electronic device and organic electronic device using the same | SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) | 2021-11-23 | — | — | US | disclosed |
| US-20180159044-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2018-06-07 | — | — | US | disclosed |
| US-20180159044-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2018-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11183641-B2 | Composition for an organic electronic device and organic electronic device using the same | ORC3, ZYX, ESR1 | PDK2 3671/4885WEE1 492/4885PLA2G2A 3769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.